Boosts in R&D Spending Drive Biotech Innovation21st Century Cures Act, Biologicals, Biotech, Diagnostics, Genetic Diseases, IDMP (Identification of Medicinal Products), Innovation, Investments, Medical Breakthroughs, Medicare Access and CHIP Authorization Act (MACRA), Nasdaq Biotech Index, R&D, Tufts Center for the Study of Drug DevelopmentFueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in R&D. Read more July 12, 2017/by Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Business Wire2017-07-12 10:15:082017-07-12 14:52:37Boosts in R&D Spending Drive Biotech Innovation
